Sarilumab antibody | AbD50191ad
A microtiter plate was coated over night with various antigens at a concentration of 5 μg/mL. After washing and blocking with PBST + 5% BSA, detection was performed using Human Anti-Sarilumab Antibody, clone AbD50191ad (TZA046) at a concentration of 2 μg/mL followed by HRP conjugated Anti-DYKDDDDK tag Antibody in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate.
A microtiter plate was coated over night with sarilumab, tocilizumab, infliximab, human IgG1 kappa control and human IgG1 lambda control at a concentration of 5 µg/mL. After washing and blocking with PBST + 5% BSA, detection was performed using Human Anti-Sarilumab Antibody, clone AbD50191ad (TZA046) titrated to the given concentrations in PBST followed by HRP conjugated Anti-DYKDDDDK tag Antibody in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate. Data is shown as the mean of three measurements.
A microtiter plate was coated over night with Human Anti-Sarilumab Antibody, clone AbD50191ad (TZA046) at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of sarilumab. Detection was performed using HRP conjugated Human Anti-Sarilumab Antibody, clone AbD51309pap (TZA047P ) at a concentration of 0.5 µg/mL in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate. Data is shown as the mean of three measurements.
A microtiter plate was coated over night with recombinant human IL-6 receptor at a concentration of 1 µg/mL. After washing and blocking with PBST + 5% BSA, a pre-incubated mixture of sarilumab (0.144 µg/mL) plus increasing concentrations of Human Anti-Sarilumab Antibody, clone AbD50191ad (TZA046) in the monovalent Fab-F-Spy2-H format was added. Free sarilumab, still capable of binding to the human IL-6 receptor coated plate, was detected using a HRP conjugated Mouse Anti-Human IgG (Fc) CH2 Domain Antibody (MCA647P) and QuantaBlu fluorogenic peroxidase substrate. Data is shown as the mean of three measurements.
Human anti Sarilumab
- Product Type
- Monoclonal Antibody
- Clone
- AbD50191ad
- Isotype
- Fab antibody
- Specificity
- Sarilumab
Antibody Quality and Performance Guarantee
TZA046
| Human Anti-Sarilumab Antibody, clone AbD50191ad is a paratope specific, inhibitory, anti-idiotypic antibody (Type 1) that specifically recognizes the free human monoclonal antibody drug sarilumab, and its biosimilar products. It does not recognize the drug target, the human Interleukin 6 receptor (IL-6R), nor sarilumab in complex with IL-6R. This antibody can be used to measure free sarilumab levels in serum from patients. A pair of anti-sarilumab antibodies can be used to develop a pharmacokinetic (PK) bridging assay to measure free drug; clone AbD50191ad is recommended as a capture antibody for sarilumab, paired with Human Anti-Sarilumab Antibody, clone AbD51309 (TZA047) as the detection antibody. TZA046 is a monovalent Fab antibody incorporating a SpyTag at the C-terminus end of the antibody heavy chain for conversion by the end user into alternative formats using any of the SpyCatchers available in our catalog. Sarilumab (trade name Kevzara) is a humanized monoclonal antibody of the IgG1/kappa isotype that suppresses the inflammatory effects of interleukin-6 (IL-6) by binding to both membrane bound and soluble IL-6 receptor forms, thus blocking cis- and trans-inflammatory signaling cascades. Through this, sarilumab blocks the IL-6 signaling pathway (measured as STAT-3 inhibition). It is indicated for the treatment of moderate to severe reactive Rheumatoid Arthritis (RA) in adult patients who are irresponsive, respond inadequately or present intolerance to disease-modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) antagonists. It is also indicated in combination with methotrexate (MTX) or as a monotherapy when there is intolerance to MTX or when MTX administration is inappropriate. |
- Product Form
- A monovalent human recombinant Fab (lambda light chain) selected from Bio-Rad’s human antibody phage display libraries expressed in a proprietary E. coli. strain. The antibody is tagged with a DYKDDDDK tag, a SpyTag version 2 (VPTIVMVDAYKRYK) and a His6-tag (HHHHHH) at the C-terminus of the antibody heavy chain. This antibody is supplied as a liquid.
- Preparation
- Metal chelate affinity chromatography
- Source
- E.coli
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.0095% MIT
- Immunogen
- Sarilumab
- Affinity
- The monovalent intrinsic affinity of Human Anti-Sarilumab Antibody, clone AbD50191ad was measured as KD = 0.02 nM by real time, label-free molecular interaction analysis on immobilized sarilumab.
- Approx. Protein Concentrations
- Antibody concentration 0.5 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
- Acknowledgements
- This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.
His-tag is a registered trademark of EMD Biosciences.
Kevzara is a registered trademark of Sanofi and Regeneron Pharmaceuticals. - Licensed Use
- For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA |  |
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
- Synonyms
- Kevzara
TZA046
168429
If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
View more products with Sarilumab specificity
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up